Clinical Trial: Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514767) titled 'Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma' on Feb. 27.

Brief Summary: This is a Phase II, single-centre, non-randomized, single-arm clinical trial to investigate the efficacy and safety of neoadjuvant nivolumab therapy in adult participants with resectable, locoregionally advanced Oral Squamous Cell Carcinoma (OSCC) tumors. Identification of predictive molecular biomarkers of tumor response to treatment will also be performed.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Oral Squamous Cell Carcinoma (OSCC)

Interventio...